Alliance Pharma expects Sanofi's ImmuCyst to be available in second half 2014
July 11 (Reuters) - Drug distributor Alliance Pharma said it now expects bladder cancer drug ImmuCyst, manufactured by Sanofi SA's vaccines unit, to become available in the second half of 2014.
Alliance Pharma told Reuters last week that it expected to start selling the drug in the first half of 2014.
Production of ImmuCyst was suspended in mid-2012 after mould was found in Sanofi Pasteur's 100-year-old manufacturing plant in Toronto, Canada.
Alliance Pharma, which acquires, markets and distributes pharmaceutical products, said that turnover in the six months ended June 30 rose 4 percent to 22.8 million pounds ($34.07 million).
- Malaysia air probe finds scant evidence of attack: sources |
- Search widened as Malaysia air probe finds scant evidence of attack |
- Confrontation in Ukraine as diplomacy stalls |
- Exclusive: Chinese raw materials also found on U.S. B-1 bomber, F-16 jets
- Freescale loss in Malaysia tragedy leads to travel policy questions